Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “AstraZeneca”

A Study to Investigate Multiple Ascending Doses of AZD5004 in Healthy Japanese Participants and Participants With Type 2 Diabetes MellitusCompleted
NCT06703658Phase 1Updated Mar 21, 2025
Sponsor: AstraZeneca
Healthy Participants · Type 2 Diabetes
Japan
Pharmacokinetic and Safety Study of Subcutaneous and Intravenous Anifrolumab Delivered in Healthy Adult ParticipantsCompleted
NCT06662123Phase 1Updated Mar 19, 2025
Sponsor: AstraZeneca
Healthy Volunteers
China
Secondary Data Analysis of Patients at Risk for CKD to Inspect CKD Prevalence, Diagnosis Rates, Diagnostic Behaviour, Treatment Patterns and Patient CharacteristicsCompleted
NCT05953701N/AUpdated Mar 19, 2025
Sponsor: AstraZeneca
Chronic Kidney Diseases
Germany
A Study to Investigate Multiple Ascending Doses and Relative Bioavailability of AZD5004 in Healthy ParticipantsCompleted
NCT06555822Phase 1Updated Mar 17, 2025
Sponsor: AstraZeneca
Healthy Participants
United States
Clinical Trial Comparing Gemcitabine and Vandetanib Therapy With Gemcitabine Alone in Pancreatic CarcinomaCompleted
NCT01601808Phase 2Updated Mar 13, 2025
Sponsor: University of Liverpool
Pancreatic Cancer
United Kingdom
Swiss Severe Asthma RegisterRecruiting
NCT03984253N/AUpdated Mar 12, 2025
Sponsor: Prof. Dr. Jörg Leuppi
Severe Asthma
Switzerland
Real-life Experience in Brazil in Patients With Castration-resistant Prostate Cancer Treated With Olaparib+AbirateroneWithdrawn
NCT06457854N/AUpdated Mar 12, 2025
Sponsor: AstraZeneca
Prostatic Neoplasms
Brazil
Prospective Multicentre Phase-IV Clinical Trial of Olaparib in Indian Patients With Ovarian and Metastatic Breast CancerCompleted
NCT04330040Phase 4Updated Mar 10, 2025
Sponsor: AstraZeneca
Ovarian Cancer · Breast Cancer
India
A Case Control Study of the Effectiveness of Q/LAIV Versus Inactivated Influenza Vaccine and No Vaccine in Subjects 2-17 Years of AgeTerminated
NCT01997450N/AUpdated Mar 10, 2025
Sponsor: MedImmune LLC
Influenza Vaccine Effectiveness
United States, United Kingdom
PAKT: AZD5363 in Combination With Paclitaxel in Triple-Negative Advanced or Metastatic Breast CancerCompleted
NCT02423603Phase 2Updated Mar 10, 2025
Sponsor: Queen Mary University of London
Metastatic Breast Cancer
France, Georgia, Hungary, Romania, South Korea +1 more
Durvalumab and Tremelimumab in Patients With Advanced Rare TumoursCompleted
NCT02879162Phase 2Updated Mar 7, 2025
Sponsor: Canadian Cancer Trials Group
Advanced Rare Tumours
Canada
Dapagliflozin Effects on Cardiometabolic Outcomes in Patients With an Acute Heart Attack.Completed
NCT04564742Phase 3Updated Mar 7, 2025
Sponsor: AstraZeneca
Acute Myocardial Infarction · Heart Failure
Sweden, United Kingdom
Sodium Zirconium Cyclosilicate to Allow Liberal Fruit and Vegetable Intake for Patients With CKD Stage 3b and 4Unknown
NCT06365684Phase 4Updated Mar 6, 2025
Sponsor: Leiden University Medical Center
Hyperkalemia · Diet Modification · Chronic Kidney Disease · Sodium Zirconium Cyclosilicate
Netherlands
Prevalence and Characterisation of Asthma Patients According to Disease Severity in PortugalCompleted
NCT05169619N/AUpdated Mar 6, 2025
Sponsor: AstraZeneca
Asthma
Portugal
QTERN (SAXAGLIPTIN/DAPAGLIFLOZIN FDC) Regulatory Post-Marketing SurveillanceCompleted
NCT05160974N/AUpdated Mar 6, 2025
Sponsor: AstraZeneca
Type 2 Diabetes Mellitus
South Korea
Improve Checkpoint-blockade Response in Advanced Urothelial CancerCompleted
NCT03871036Phase 1, Phase 2Updated Mar 6, 2025
Sponsor: The Netherlands Cancer Institute
Urothelial Carcinoma
Netherlands
Disease Management Platform for Heart Failure (DMP-HF)Completed
NCT04782973NAUpdated Mar 5, 2025
Sponsor: Massachusetts General Hospital
Heart Failure
United States
The Prevalence Evaluation of Systemic Lupus Erythematosus in Russian Patients With Reproductive Issues (PRISMA)Completed
NCT06056778N/AUpdated Feb 28, 2025
Sponsor: AstraZeneca
Systemic Lupus Erythematosus
Russia
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of a Single Ascending Dose of AZD0292 In Healthy ParticipantsCompleted
NCT06311760Phase 1Updated Feb 27, 2025
Sponsor: AstraZeneca
Healthy Participants Study
United States
A Phase II, Randomized, Double-blind, Placebo-controlled Study to Assess MEDI3506 in Participants With COPD and Chronic BronchitisCompleted
NCT04631016Phase 2Updated Feb 27, 2025
Sponsor: AstraZeneca
Chronic Obstructive Pulmonary Disease (COPD) · Chronic Bronchitis
United States, Australia, Canada, Czechia, Denmark +10 more
Real-world Dapagliflozin Experience in Patients With Heart Failure in United Kingdom.Completed
NCT05188144N/AUpdated Feb 25, 2025
Sponsor: AstraZeneca
Heart Failure
United Kingdom
Combining Anti-PD-L1 Immune Checkpoint Inhibitor Durvalumab With TLR-3 Agonist Rintatolimod in Patients With Metastatic Pancreatic Ductal Adenocarcinoma for Therapy EfficacyRecruiting
NCT05927142Phase 1, Phase 2Updated Feb 25, 2025
Sponsor: Joachim Aerts, MD PhD
Metastatic Pancreatic Cancer
Netherlands
Efficacy and Safety of MEDI6570 in Patients With a History of Myocardial InfarctionCompleted
NCT04610892Phase 2Updated Feb 21, 2025
Sponsor: AstraZeneca
Coronary Heart Disease (CHD)
United States, Australia, Canada, Czechia, Hungary +6 more
A Phase I Study to Investigate the Effect of Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of AZD0780Completed
NCT06592482Phase 1Updated Feb 20, 2025
Sponsor: AstraZeneca
Renal Impairment
United States
A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD7503 in Healthy ParticipantsCompleted
NCT05143905Phase 1Updated Feb 19, 2025
Sponsor: AstraZeneca
Safety · Tolerability · Pharmacokinetics · Healthy Participants
United States

Previous page Next page